Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009010107 - USE OF EPO RECEPTOR ACTIVATION OR STIMULATION FOR THE IMPROVEMENT OF THE EDSS SCORE IN PATIENTS WITH MULTIPLE SCLEROSIS

Publication Number WO/2009/010107
Publication Date 22.01.2009
International Application No. PCT/EP2008/000728
International Filing Date 30.01.2008
IPC
A61K 38/18 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
A61P 25/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
CPC
A61K 38/1816
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
18Growth factors; Growth regulators
1816Erythropoietin [EPO]
A61P 25/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 37/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
02Immunomodulators
Applicants
  • EHRENREICH, Hannelore [DE]/[DE]
Inventors
  • EHRENREICH, Hannelore
Agents
  • PFENNING, MEINIG & PARTNER GbR
Priority Data
07014225.219.07.2007EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF EPO RECEPTOR ACTIVATION OR STIMULATION FOR THE IMPROVEMENT OF THE EDSS SCORE IN PATIENTS WITH MULTIPLE SCLEROSIS
(FR) UTILISATION D'ACTIVATION OU DE STIMULATION DU RÉCEPTEUR DE L'EPO POUR L'AMÉLIORATION DU SCORE EDSS DANS DES PATIENTS PRÉSENTANT UNE SCLÉROSE EN PLAQUES
Abstract
(EN)
The present invention concerns a Method for the improvement of the expanded disability status scale (EDSS) score achieved by mammals affected by multiple sclerosis, wherein a substance effecting increased and/or prolonged activation and/or stimulation of the erythropoietin receptor is applied to the mammal.
(FR)
La présente invention porte sur un procédé pour améliorer le score d'échelle étendue d'incapacité de Kurtz ke (EDSS) obtenu par des mammifères atteints d'une sclérose en plaques, suivant lequel une substance effectuant une activation et/ou stimulation accrue et/ou prolongée du récepteur de l'érythropoïétine est appliquée au mammifère.
Also published as
Latest bibliographic data on file with the International Bureau